Anti Cardiolipin Control - ARCSA Registration 260c5955500834736c30d149048e0086
Access comprehensive regulatory information for Anti Cardiolipin Control in the Ecuador medical device market through Pure Global AI's free database. This I medical device is registered under ARCSA ID 260c5955500834736c30d149048e0086 and manufactured by SHENZHEN YHLO BIOTECH CO., LTD.. The device was registered on October 12, 2021.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
Free Database
Powered by Pure Global AI
ARCSA Official Data
I
260c5955500834736c30d149048e0086
Anti Cardiolipin Control
ARCSA ID: 260c5955500834736c30d149048e0086
Device Classification
Risk Class
I
Product Type
In Vitro Diagnostic
Brand Name
YHLO
Commercial Name
17-061 IVD Reagents/Assay Kits, Immunoassay, Control
Registration Information
Analysis ID
260c5955500834736c30d149048e0086
Registration Date
October 12, 2021
Expiration Date
October 12, 2026
Product Use
ANTI CARDIOLIPIN CONTROL IS USED TO CHECK THE RELIABILITY OF THE ANTI CARDIOLIPIN ASSAY.
Manufacturer
City
SHENZHEN
Country
CHINA
Address
BUILDING 1, YHLO BIOPARK, BAOLONG 2ND ROAD, BAOLONG SUBDISTRICT, LONGGANG DISTRICT, 518116 SHENZHEN, PEOPLE'S REPUBLIC OF CHINA
Product Owner
Name
SHENZHEN YHLO BIOTECH CO., LTD.
Country
CHINA
Authorized Representative